Archive

Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.

South Africa’s population grew by an estimated 1.2% in the year to June 2026. This brought the total population to 63.52 million, according to the latest mid-year population estimates from Statistics South Africa. The rate was broadly unchanged from 2025. During that year, the population increased by 1.23% to 63.1 million. South Africa’s population has […]

Sixty60 pharmacy delivery could reset South Africa’s chemist market, letting Shoprite’s Medirite challenge Clicks and Dis-Chem.

Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.

Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.

Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.

Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.

The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family’s representation.

The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.